title: Reply to M. Koehler et al.
authors.affiliation: Italian Group for Adult Hematologic Diseases Data Center and Health Outcomes Research Unit, Rome, Italy f.efficace@gimema.it.
authors.forename: Fabio
authors.initials: F
authors.lastname: Efficace
authors.affiliation: Italian Group for Adult Hematologic Diseases Data Center and Health Outcomes Research Unit, Rome, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Cottone
authors.affiliation: Università Tor Vergata; Fondazione Santa Lucia, Rome, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Lo-Coco
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001152:Arsenicals / Q000627:therapeutic use*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D010087:Oxides / Q000627:therapeutic use*; D011788:Quality of Life; D014212:Tretinoin / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D014212:Tretinoin